Workshop on suramin with emphasis on prostate cancer: Re-evaluation of response criteria
- 31 December 1993
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (3) , 298-300
- https://doi.org/10.1016/0959-8049(93)90370-u
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Adaptive control with feedback strategies for suramin dosingClinical Pharmacology & Therapeutics, 1992
- Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer.Journal of Clinical Oncology, 1992
- Therapeutic Drug Monitoring of Suramin and Protein BindingJournal of Liquid Chromatography, 1991
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- A Phase III Trial of Zoladex and Flutamide Versus Orchiectomy in the Treatment of Patients With Advanced Carcinoma of the ProstateCancer, 1990
- Some Limitations of the Radioisotope Bone Scan in Patients With Metastatic Prostatic CancerCancer, 1990
- Synergistic Activity of Suramin With Tumor Necrosis Factor and Doxorubicin on Human Prostate Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1990
- Suramin‐induced polyneuropathyNeurology, 1990
- Treatment response criteria for prostatic cancerThe Prostate, 1984
- Reporting results of cancer treatmentCancer, 1981